<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Bielefeld-CeBiTec_Applied_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Bielefeld-CeBiTec/Applied Design</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="navbar left"><UL class="navbar-paragraph left"><LI class="navbar-paragraph left"><A class="no-link" href="https://2017.igem.org/Team:Bielefeld-CeBiTec">Expanding the Genetic Code</A></LI></UL><UL class="navbar" id="navbar-left"><LI class="navbar item-left" id="hp"><A>Human Practice ▼</A></LI><LI class="navbar item-left" id="specials"><A>Additional ▼</A></LI><LI class="navbar item-left" id="results"><A>Results ▼</A></LI><LI class="navbar item-left" id="project"><A>Theory ▼</A></LI></UL></DIV><DIV class="navbar right"><UL class="navbar-paragraph right"><LI class="navbar-paragraph right"><A class="no-link" href="https://2017.igem.org/Team:Bielefeld-CeBiTec">Bielefeld-CeBiTec 2017</A></LI></UL><UL class="navbar" id="navbar-right"><LI class="navbar item-right" id="collaborations"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Collaborations">Collaborations</A></LI><LI class="navbar item-right" id="team"><A>Team ▼</A></LI><LI class="navbar item-right" id="partners"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Partners">Partners</A></LI><LI class="navbar item-right" id="notebook"><A>Notebook ▼</A></LI></UL></DIV><DIV class="sub-navbar"><UL class="sub-navbar-list" id="navbar-project"><LI class="sub-navbar-item" id="project-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/Overview">Aim of the Project</A></LI><LI class="sub-navbar-item" id="project-ubp"><A>Unnatural Base Pair ▼</A></LI><LI class="sub-navbar-item" id="project-translation"><A>Translational System ▼</A></LI><LI class="sub-navbar-item" id="project-toolbox"><A>Toolbox ▼</A></LI></UL><UL class="sub-navbar-list" id="navbar-project-ubp"><LI class="sub-navbar-item small" id="project-ubp-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair">Overview</A></LI><LI class="sub-navbar-item small" id="project-ubp-ubp"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/unnatural_base_pairs">Unnatural Base Pairs</A></LI><LI class="sub-navbar-item small" id="project-ubp-uptake"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/uptake_and_biosynthesis">Uptake and Biosynthesis</A></LI><LI class="sub-navbar-item small" id="project-ubp-preservation"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/preservation_system">Retention System</A></LI><LI class="sub-navbar-item small" id="project-ubp-challenges"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/challenges">Challenges </A></LI></UL><UL class="sub-navbar-list" id="navbar-project-translation"><LI class="sub-navbar-item small" id="project-translation-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/translational_system">Overview</A></LI><LI class="sub-navbar-item small" id="project-translation-mechanism"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/translational_system/translation_mechanism">Translation Mechanism</A></LI><LI class="sub-navbar-item small" id="project-translation-library"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/translational_system/library_and_selection">Library and Selection</A></LI></UL><UL class="sub-navbar-list" id="navbar-project-toolbox"><LI class="sub-navbar-item small" id="project-toolbox-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox">Overview</A></LI><LI class="sub-navbar-item small" id="project-toolbox-analysing"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox/analysing">Analyzing</A></LI><LI class="sub-navbar-item small" id="project-toolbox-photoswitching"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox/photoswitching">Photoswitching</A></LI><LI class="sub-navbar-item small" id="project-toolbox-labeling"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox/labeling">Labeling</A></LI><LI class="sub-navbar-item small" id="project-toolbox-photolysis"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox/photolysis">Photolysis</A></LI><LI class="sub-navbar-item small" id="project-toolbox-fusing"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox/fusing">Fusing</A></LI></UL><UL class="sub-navbar-list" id="navbar-results"><LI class="sub-navbar-item" id="results-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Demonstrate">Results Overview</A></LI><LI class="sub-navbar-item" id="results-ubp"><A>Unnatural Base Pair ▼</A></LI><LI class="sub-navbar-item" id="results-translation"><A>Translational System ▼</A></LI><LI class="sub-navbar-item" id="results-toolbox"><A>Toolbox ▼</A></LI><LI class="sub-navbar-item" id="results-parts"><A>Parts ▼</A></LI><LI class="sub-navbar-item" id="results-achievements"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Achievements">Achievements</A></LI></UL><UL class="sub-navbar-list" id="navbar-results-ubp"><LI class="sub-navbar-item small" id="results-ubp-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair">Overview</A></LI><LI class="sub-navbar-item small" id="results-ubp-uptake"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair/uptake">Uptake</A></LI><LI class="sub-navbar-item small" id="results-ubp-biosynthesis"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair/biosynthesis">Biosynthesis</A></LI><LI class="sub-navbar-item small" id="results-ubp-preservation"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair/preservation_system">Retention System</A></LI><LI class="sub-navbar-item small" id="results-ubp-new_methods"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair/development_of_new_methods">Development of New Methods </A></LI></UL><UL class="sub-navbar-list" id="navbar-results-translation"><LI class="sub-navbar-item small" id="results-translation-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/translational_system">Overview</A></LI><LI class="sub-navbar-item small" id="results-translation-mechanism"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/translational_system/translation_mechanism">Translation Mechanism</A></LI><LI class="sub-navbar-item small" id="results-translation-library"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/translational_system/library_and_selection">Library and Selection</A></LI></UL><UL class="sub-navbar-list" id="navbar-results-toolbox"><LI class="sub-navbar-item small" id="results-toolbox-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox">Overview</A></LI><LI class="sub-navbar-item small" id="results-toolbox-analysing"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox/analysing">Analyzing</A></LI><LI class="sub-navbar-item small" id="results-toolbox-photoswitching"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox/photoswitching">Photoswitching</A></LI><LI class="sub-navbar-item small" id="results-toolbox-labeling"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox/labeling">Labeling</A></LI><LI class="sub-navbar-item small" id="results-toolbox-photolysis"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox/photolysis">Photolysis</A></LI><LI class="sub-navbar-item small" id="results-toolbox-fusing"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox/fusing">Fusing</A></LI></UL><UL class="sub-navbar-list" id="navbar-results-parts"><LI class="sub-navbar-item small" id="results-parts-parts"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Parts">Parts</A></LI><LI class="sub-navbar-item small" id="results-parts-basic"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Basic_Part">Basic Parts</A></LI><LI class="sub-navbar-item small" id="results-parts-composite"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Composite_Part">Composite Parts</A></LI><LI class="sub-navbar-item small" id="results-parts-collection"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Part_Collection">Part Collection</A></LI><LI class="sub-navbar-item small" id="results-parts-improve"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Improve">Improve</A></LI></UL><UL class="sub-navbar-list" id="navbar-specials"><LI class="sub-navbar-item" id="hardware"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Hardware">Hardware</A></LI><LI class="sub-navbar-item" id="software"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Software">Software</A></LI><LI class="sub-navbar-item" id="modelling"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Model">Modeling</A></LI><LI class="sub-navbar-item" id="measurement"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Measurement">Measurement</A></LI><LI class="sub-navbar-item" id="applied-design"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Applied_Design">Applied Design</A></LI><LI class="sub-navbar-item" id="results-ils"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/InterLab">InterLab Study</A></LI></UL><UL class="sub-navbar-list" id="navbar-hp"><LI class="sub-navbar-item" id="hp-overview"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/HP">Overview</A></LI><LI class="sub-navbar-item" id="hp-gold"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/HP/Gold_Integrated">Gold</A></LI><LI class="sub-navbar-item" id="hp-silver"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/HP/Silver">Silver</A></LI><LI class="sub-navbar-item" id="hp-pe"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Engagement">Public Engagement</A></LI></UL><UL class="sub-navbar-list" id="navbar-team"><LI class="sub-navbar-item" id="team-members"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Team">Members</A></LI><LI class="sub-navbar-item" id="team-advisors"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Team/Advisors">Advisors</A></LI><LI class="sub-navbar-item" id="team-bielefeld"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Team/Bielefeld">Bielefeld</A></LI><LI class="sub-navbar-item" id="team-cebitec"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Team/CeBiTec">CeBiTec</A></LI><LI class="sub-navbar-item" id="team-uni"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Team/Bielefeld_University">Bielefeld University</A></LI><LI class="sub-navbar-item" id="team-attributions"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Attributions">Attributions</A></LI></UL><UL class="sub-navbar-list" id="navbar-notebook"><LI class="sub-navbar-item" id="notebook-methods"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Methods">Methods</A></LI><LI class="sub-navbar-item" id="notebook-oligonucleotides"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides">Oligonucleotides</A></LI><LI class="sub-navbar-item" id="notebook-labjournal"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Labjournal">Labjournal</A></LI><LI class="sub-navbar-item" id="notebook-lng"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/LabnotesGenerator">Labnotes Generator</A></LI><LI class="sub-navbar-item" id="notebook-safety"><A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Safety">Safety</A></LI></UL></DIV><DIV class="container"><DIV id="title" style="background-image: url(https://static.igem.org/mediawiki/2017/7/77/T--Bielefeld-CeBiTec--title-img-toolbox2.jpg);"><DIV id="title-bg"><DIV id="title-text">
						Applied Design
					</DIV></DIV></DIV><DIV class="contentbox"><DIV class="content"><H3>Short summary</H3><DIV class="article">
			Terminus independent specific fusion of two or more peptides is a major challenge in synthetic biology and beyond. 
			Inspired by the highly specific condensation reaction of D‑luciferin from the firefly <I>Photinus pyralis</I>, we came up 
			with a sophisticated solution, combining organic chemistry, computational modelling, and molecular biology. Based on 
			our own design, we synthesized the novel synthetic amino acid <I>N</I><SUP>γ</SUP>‑cyanobenzothiazolyl‑L‑asparagine‑(CBT‑asparagine). 
			The cyano group of CBT‑asparagine undergoes a condensation reaction with the 1,2‑aminothiol group of <I>N</I><SUP>ε</SUP>‑L‑cysteinyl‑L‑lysine (CL). 
			Through <I>in silico</I> simulation, we predicted different aminoacyl tRNA synthetase sequences to incorporate CBT‑asparagine into 
			proteins of interest. This system offers a new way for the production of fusion proteins and polymerized polypeptides.
		</DIV></DIV></DIV><DIV class="contentbox"><DIV class="content"><H3>Searching for Interesting Non-Canonical Amino Acids</H3><DIV class="article">
			During our search for interesting non‑canonical amino acids which we could use for our project, we found CL. It was first synthesized 
			and described by Nguyen <I>et al</I>. (2011). It is proposed that CL enables the highly specific binding between peptides and ligands containing 
			a cyanobenzothiazole residue. CL itself consists of L‑cysteine coupled by its carboxy group to the amino group of the side chain of 
			L‑lysine. As a result, it contains a free 1,2‑aminothiol group at its side chain. According to the highly specific condensation reaction 
			of 1,2‑aminothiols and cyanobenzothiazole‑derivatives (CBT-derivatives), which is common for the biosynthesis of D‑Luciferin (see Figure 
			1), the substrate of the firefly luciferase of <I>P. pyralis</I>, CL can undergo the same condensation reaction with CBT‑derivatives (see 
			Figure 2).
		</DIV><DIV class="figure large"><P class="figure subtitle"><B>Figure 1: Synthesis of D‑Luciferin.</B> The 1,2‑aminothiol group of D‑cysteine and the 
			6‑hydroxybenzothiazole‑2‑carbonitrile undergo the condensation reaction under physiological conditions to build D‑luciferin 
			(Liang <I>et al</I>., 2010).</P></DIV><DIV class="figure large"><P class="figure subtitle"><B>Figure 2: The condensation reaction of CL and a CBT‑derivative. </B> The 1,2‑aminothiol group 
			of the side chain of CL and the cyano group of the CBT‑derivative undergo the same condensation reaction under physiological conditions 
			like D‑cysteine and 6‑hydroxybenzothiazole‑2‑carbonitrile.</P></DIV><DIV class="article">
			So far, CL was used to label proteins with CBT‑derivatives bound to fluorescent chemicals and proteins. Inspired by the rapid and 
			highly specific condensation reaction which takes place under physiological conditions, we thought about a possibility to synthesize 
			a novel amino acid which enables the highly specific binding between peptides using CBT as a side chain and CL as the counterpart.
		</DIV></DIV></DIV><DIV class="contentbox"><DIV class="content"><H3>Designing a Novel Amino Acid</H3><DIV class="article">
			To synthesize a novel amino acid, we needed the right reagents for the reaction. First, it was important to find a CBT‑derivative 
			which could be coupled to the side chain of a canonical amino acid. To use common methods of peptide synthesis, we needed two 
			educts one containing a free carboxy group and one containing a free amino group. There are different canonical amino acids containing 
			one of these two groups at their side chains. All canonical eligible amino acids with a free amino group at their side chain are lysine, 
			asparagine and glutamine. Because of the long carbon chain at the side chain of lysine it would be too difficult to generate a well 
			working aminoacyl‑tRNA synthetase for a novel amino acid consisting of lysine and a CBT‑derivative. To get an amino acid as small as 
			possible containing a CBT-derivative at its side chain, asparagine and its derivative aspartic acid which contains a free carboxy group 
			at its side chain were the best choices for an educt for the synthesis of a novel amino acid. As CBT-derivative we chose 
			6‑amino‑2‑cyanobenzothiazole (ACBT) which has a free amino group at its benzene ring (see Figure 3). Its free amino group ACBT 
			requires an aspartic acid for the coupling reaction to synthesize the novel amino acid.
		</DIV><DIV class="figure medium"><P class="figure subtitle"><B>Figure 3: Structure of ACBT. </B>The amino group at the benzene ring can be used for the 
			coupling reaction and the cyano group at the thiazole ring enables the condensation reaction.</P></DIV></DIV></DIV><DIV class="contentbox"><DIV class="content"><H3>Synthesizing a Novel Amino Acid</H3><DIV class="article">
			Due to the high price of ACBT, we synthesized it first on ourselves using 2‑chloro‑6‑nitrobenzothiazole (Cl-NBT) as educt. According 
			to Hauser <I>et al</I>. (2016), we produced ACBT by the nucleophilic substitution of the chlorine atom with a cyano group and the reduction of 
			the nitro group to an amino group. Figure 4 shows the schematic synthesis of ACBT with Cl‑NBT as the educt.
		</DIV><DIV class="figure large"><P class="figure subtitle"><B>Figure 4: Schematic synthesis of ACBT with Cl‑NBT as the educt. </B> First, the chlorine atom of the 
			Cl‑NBT is substituted with a cyano group (i) to give 6‑nitrobenzothiazole‑2‑carbonitrile (NBT‑CN). The second step is the reduction 
			of the nitro group of NBT‑CN to an amino group (ii) resulting in ACBT.</P></DIV><DIV class="article">
			With ACBT and <I>N</I>‑Fmoc‑aspartic acid‑OAllyl ester we could synthesize the novel amino acid CBT‑asparagine. 
			Figure 5 and 6 show the two steps of the synthesis.
		</DIV><DIV class="figure large"><P class="figure subtitle"><B>Figure 5: Schematic coupling reaction of ACBT and <I>N</I>‑Fmoc‑aspartic acid‑OAllyl ester. </B> Due to the 
			protecting groups, only the carboxy group of <I>N</I>‑Fmoc‑aspartic acid‑OAllyl ester can react with the amino group of ACBT. Using isobutyl 
			chloroformate and 4‑methylmorpholine enables the coupling reaction.</P></DIV><DIV class="figure large"><P class="figure subtitle"><B>Figure 6: Deprotection of <I>N</I>‑Fmoc‑CBT‑asparagine‑OAllyl ester.</B>By adding 3x the equivalent of morpholine to 
			the protected <I>N</I>‑Fmoc‑CBT‑asparagine‑OAllyl ester, we could directly remove both protecting groups resulting in the free form of the novel 
			amino acid CBT-asparagine.</P></DIV><DIV class="article">
			With the novel amino acid CBT‑asparagine and the CL we provide a new way of rapid highly specific binding of peptides and enzymes 
			under physiological conditions. First <A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/toolbox/fusing"><I>in vitro</I> tests </A> show that the condensation reaction 
			between CBT‑asparagine and CL (see Figure 7) takes place.
		</DIV><DIV class="figure large"><P class="figure subtitle"><B>Figure 7: Schematic condensation reaction of CL and CBT‑asparagine.</B>The natural 
			condensation reaction of 1,2‑aminothiols and 6‑hydroxybenzothiazole‑2‑carbonitrile provides a new way to produce fusion proteins and polymer peptides by binding both amino acids.</P></DIV></DIV></DIV><DIV class="contentbox"><DIV class="content"><H3>Modeling New Aminoacyl-tRNA Synthetases by in silico Simulation</H3><DIV class="article">
			Additionally, we generated several new aminoacyl‑tRNA synthetases based on the tyrosyl‑tRNA synthetase of <I>Methanococcus jannaschii</I> 
			using the protein design software ROSETTA. Preliminary tests indicate that the modeled synthetases <A href="http://parts.igem.org/Part:BBa_K2201300">K2201300</A>, <A href="http://parts.igem.org/Part:BBa_K2201301">K2201301</A>, and <A href="http://parts.igem.org/Part:BBa_K2201302">K2201302</A> are able to incorporate CBT‑asparagine (for 
			further information visit our <A href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Model"> modeling page</A>). Further tests are needed to
			evluate these results. Following figure shows CBT‑asparagine in the binding site of the synthetase <A href="http://parts.igem.org/Part:BBa_K2201300">K2201300</A> (Figure 8).
		<DIV class="figure medium"><P class="figure subtitle"><B>Figure 8: CBT-asparagine in the binding site of <A href="http://parts.igem.org/Part:BBa_K2201300">K2201300</A>.</B></P></DIV></DIV><H3>Conclusion</H3><DIV class="article">
			We provide a new way to produce fusion proteins and polymerized peptides using the terminus independent, rapid and highly specific 
			binding ability of CL and the novel amino acid CBT‑asparagine. With this method, it is possible to fuse peptides and enzymes using 
			an environmentally friendly condensation reaction which is inspired by natural systems.
		</DIV></DIV></DIV><DIV class="contentbox"><DIV class="content"><H3>References</H3><DIV class="article"><B>Hauser, J.R., Beard, H.A., Bayana, M.E., Jolley, K.E., Warriner, S.L., and Bon, R.S.</B> (2016). Economical and scalable synthesis of 6-amino-2-cyanobenzothiazole. Beilstein J. Org. Chem. <B>12</B>: 2019–2025.
			<B>Liang, G., Ren, H., and Rao, J.</B> (2010). A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. <B>2</B>: 54–60.
			<B>Nguyen, D.P., Elliott, T., Holt, M., Muir, T.W., and Chin, J.W.</B> (2011). Genetically Encoded 1,2-Aminothiols Facilitate Rapid and Site-Specific Protein Labeling via a Bio-orthogonal Cyanobenzothiazole Condensation. J. Am. Chem. Soc. <B>133</B>: 11418–11421.
		</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>